Studying VELGRAFT for diabetic foot ulcers
Part of Heart & circulation, Hormones & metabolism, Skin clinical trials.
This trial tests a new treatment called VELGRAFT, which is made from living cells, for diabetic foot ulcers that haven't healed with standard care. The goal is to see if it can help the wound close and heal more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have type 1 or type 2 diabetes.
- Your foot ulcer has been there for 4 weeks to 6 months, is between 1 and 20 cm² (about the size of a quarter to a credit card), and is deep enough to involve the skin and under-layer but not expose muscle, tendon, or bone.
- You have good blood flow to your foot, confirmed by a recent test (like ankle-brachial index or Doppler).
- You don't have an active infection, gangrene, or a history of amputation on that foot.
- You haven't had certain treatments (like chemotherapy, steroids, or other wound-healing products) in the past month and are willing to wear a special shoe or boot to take pressure off the ulcer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new wound gel helps heal diabetic foot ulcers better than the standard gel. It is for people with mild to moderate foot ulcers who have good blood flow and are not taking certain medications.
This study tests a new wound therapy for diabetic foot ulcers that haven't healed with standard care. It aims to see if the therapy helps these ulcers heal better and faster.
This trial tests whether an amniotic tissue treatment can help heal chronic diabetic foot ulcers that haven't improved with standard care. It focuses on a single ulcer below the ankle that has been present for more than 4 weeks but less than a year.
This trial compares several advanced wound treatments (called CAMPs) plus standard care versus standard care alone for diabetic foot ulcers that are slow to heal. The goal is to see if adding these treatments helps ulcers close faster.
This study tests a new wound dressing made from amniotic membrane, called Xcell Amnio Matrix, to see if it helps heal diabetic foot ulcers that have not healed with standard treatments. If you qualify, you would receive the dressing along with regular wound care.
This trial tests a new treatment using special skin cells grown into tiny spheres (spheroids) to help heal diabetic foot ulcers that have not healed with standard care. It aims to see if this treatment is safe and works better than usual care.
Hear when a new Diabetic Foot Ulcer (DFU) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.